Product
Allogeneic Cardiosphere-Derived Cells
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
Open-Label Extension of the Halt Cardiomyopathy Progression in Duchenne (HOPE-Duchenne) Trial (CAP-1002-DMD-03)Status: Completed, Estimated PCD: 2019-03-06